Predictive value of peripheral blood markers in soft tissue sarcoma patients treated with eribulin

CONCLUSIONS: the combined indicator of low NLR prestart and high ALC8D predicted the survival of patients treated with eribulin as well as the histology of L-sarcoma. Though further validation was needed, this finding would provide valuable prognostic factor that help treatment decision in the absence of consensus on the optimal second-line therapy following doxorubicin treatment in STS patients.PMID:36989466 | DOI:10.1093/jjco/hyad021

Source: Clinical Breast Cancer - March 29, 2023 Category: Cancer & Oncology Authors: Shin Ishihara Koichi Ogura Aiko Maeshima Tatsunori Shimoi Kazuki Sudo Yuki Kojima Suguru Fukushima Shuhei Osaki Eisuke Kobayashi Shintaro Iwata Yoshiyuki Matsui Kan Yonemori Akira Kawai Source Type: research